Catalyst Wire Dossier Catalyst Wire Dossier

melphalan flufenamide

melphalan flufenamide · Oncopeptides AB
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for melphalan flufenamide, covering 2022-02-01 to 2022-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Study of Melphalan Flufenamide (Melflufen) + Dex With Bortezomib or Daratumumab in Patients With RRMM [Phase 1, Phase 2]

See pricing